Search

Your search keyword '"Gallia, Gary L."' showing total 394 results

Search Constraints

Start Over You searched for: Author "Gallia, Gary L." Remove constraint Author: "Gallia, Gary L." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
394 results on '"Gallia, Gary L."'

Search Results

1. The Quiet Eye Phenomenon in Minimally Invasive Surgery

3. Contributors

5. Impact of Antithrombotic Medications and Reversal Strategies on the Surgical Management and Outcomes of Traumatic Acute Subdural Hematoma

9. Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

10. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

11. 124 Craniotomy Versus Craniectomy for Traumatic Acute Subdural Hematoma Coarsened Exact Matched Analysis of Outcomes

15. Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.

16. Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.

19. Impact of antithrombotic medications and reversal strategies on the surgical management and outcomes of traumatic acute subdural hematoma

23. Risk of Subdural Hematoma Expansion in Patients With End-Stage Renal Disease: Continuous Venovenous Hemodialysis Versus Intermittent Hemodialysis.

25. International consensus statement on allergy and rhinology: Sinonasal tumors

26. Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

29. Awake Versus Asleep Craniotomy for Patients With Eloquent Glioma: A Systematic Review and Meta-Analysis

33. Supplementary Table 1 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

34. Supplementary Methods from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

35. Supplementary Table 2 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

36. Supplementary Figures 1 - 5 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

37. Supplementary Table 3 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

38. Data from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

39. Supplementary Figure Legend from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

40. 772 Re-examining the Role of Post-Operative ICU Admission for Patients Undergoing Elective Craniotomy: A Systematic Review

48. Data Supplement from TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting

Catalog

Books, media, physical & digital resources